Picture of MAC Alpha logo

MACA MAC Alpha News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsHighly SpeculativeSmall CapSucker Stock

REG - MAC Alpha Limited - Annual Financial Report

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231010:nRSJ4592Pa&default-theme=true

RNS Number : 4592P  MAC Alpha Limited  10 October 2023

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN
WHICH IT WOULD BE UNLAWFUL TO DO SO

 

LEI: 254900LOBYWJWYSAB947

 

MAC Alpha Limited

(the "Company")

Publication of the Annual Report and Financial Statements for the year ended
30 June 2023

The Company announces the publication of its Annual Report and Financial
Statements for the year ended 30 June 2023.

 

The Annual Report and Financial Statements are also available on the
'Shareholder Documents' page of the Company's website at www.mac-alpha.com
(http://www.mac-alpha.com) .

 

Enquiries:

Company Secretary

Antoinette Vanderpuije - 020 7004 2700

 

 MAC ALPHA LIMITED

 

Annual Report and Audited Consolidated Financial Statements

For the year ended 30 June 2023

 

 

MANAGEMENT REPORT

We present to shareholders the audited consolidated financial statements of
MAC Alpha Limited (the "Company") for the year ended 30 June 2023 (the
"Financial Statements"), consolidating the results of MAC Alpha Limited and
its subsidiary, MAC Alpha (BVI) Limited (collectively, the "Group" or "MAC").

 

Strategy

The Company was incorporated on 11 October 2021 and subsequently listed on the
Main Market of the London Stock Exchange on 24 December 2021. The Company has
been formed for the purpose of effecting a merger, share exchange, asset
acquisition, share or debt purchase, reorganisation, or similar business
combination with one or more businesses. The Company's objective is to
generate attractive long term returns for shareholders and to enhance value by
supporting sustainable growth, acquisitions, and performance improvements
within the acquired companies.

While a broad range of sectors will be considered by the Directors, those
which they believe will provide the greatest opportunity and which the Company
will initially focus on include:

•              Automotive & Transport;

•              Business-to-Business Services;

•              Clean Technology;

•              Consumer & Luxury Goods;

•              Financial Services, Banking & Fin Tech;

•              Insurance, Reinsurance & InsurTech, &
Other Vertical Marketplaces;

•              Media & Technology; and

•              Healthcare & Diagnostics.

The Directors may consider other sectors if they believe such sectors present
a suitable opportunity for the Company.

The Company will seek to identify situations where a combination of management
expertise, improving operating performance, freeing up cashflow for investment
and implementation of a focussed buy and build strategy can unlock growth in
their core markets and often into new territories and adjacent sectors.

 

Activity

During the year the Directors have engaged with a number of potential
management teams, attracted by the Company's flexible structure and main
market listing. Desktop due diligence has been conducted on sectoral
opportunities in which the prospective management teams have extensive
experience. While none of these opportunities have yet progressed to the
appointment of a management partner, or completing a platform acquisition,
discussions remain active.

 

Results
The Group's total comprehensive loss for the year to 30 June 2023 was
£323,463 (period from incorporation to 30 June 2022: £266,043). Of the costs
incurred in the year, £15,798 (period from incorporation to 30 June 2022:
£61,872) relates to non-recurring project costs. During the year, the Company
raised £600,000 (period from incorporation to 30 June 2022: £700,000)
through the issue of equity (excluding expenses) and held a cash balance at 30
June 2023 of £554,446 (2022: £282,244). The Group has not yet acquired an
operating business and as such is not yet income generating.

 

Directors

The Directors of the Company who served during the year are:

James Corsellis (Chairman);

Tom Basset (Non-Executive Director) (appointed 6 November 2022);

Antoinette Vanderpuije (Non-Executive Director) (appointed 6 November 2022);
and

Mark Brangstrup Watts (Executive Director) (resigned 6 November 2022).

Directors' Biographies

James Corsellis

James brings extensive public company experience as well as management and
corporate finance expertise across a range of sectors and an extensive network
of relationships with co-investors, advisers and other business leaders.

Previously James has served as a director of the following companies: a
non-executive director of BCA Marketplace Limited (formerly BCA Marketplace
Plc) from July 2014 to December 2017, Advanced Computer Software from October
2006 to August 2008, non-executive chairman of Entertainment One Limited from
January 2007 to March 2014 and remaining on the board as a non-executive
director until July 2015, non-executive director of Breedon Aggregates Limited
from March 2009 to July 2011 and as CEO of icollector Plc from 1994-2001
amongst others. James was educated at Oxford Brookes University, the Sorbonne
and London University.

James is currently the managing partner of Marwyn Capital LLP and Marwyn
Investment Management LLP, an executive director of Silvercloud Holdings
Limited, the chairman of Marwyn Acquisition Company III Limited, and a
director of 450 Plc, Marwyn Acquisition Company II Limited and Plamer Street
Limited.

Tom Basset

Tom has extensive experience working across a range of sectors in the
origination and assessment of new investment opportunities, transaction
execution, coordinating capital market and M&A processes and providing
strategic corporate advice to management teams. Tom joined Marwyn in 2010,
where he now leads the Investment Team and is also a member of the Investment
Committee. Prior to Marwyn, Tom spent six years at Deloitte across the
Assurance & Advisory and Private Equity Transaction Services groups. Tom
is a qualified Chartered Accountant and graduated from Durham University with
a BA (Hons) in Economics.

Tom is a non-executive director of 450 plc and Marwyn Acquisition Company III
limited and a director of Silvercloud Holdings Limited.

Antoinette Vanderpuije

Antoinette has been a partner of the Marwyn group for over ten years and leads
the Finance, Markets and Regulation Team. She has extensive M&A and board
experience with a particular focus on corporate governance, regulation and
listing requirements, transaction tax structuring and incentive planning.
Antoinette has supported numerous private and public companies with their
day-to-day finance, company secretarial and operational requirements and
worked on numerous U.K. and cross border M&A transactions in sectors as
varied as online sales, transport, media, chemicals and manufacturing and
distribution.

Antoinette is also a member of Marwyn's Investment Committee and previously
ran Marwyn's award-winning in-house administration business.

Antoinette previously worked in the finance team at Arcadia Group and prior to
that with Bourner Bullock Chartered Accountants. She is a Chartered
Accountant, a Chartered Tax Advisor and holds a BA from University College
London.

Antoinette is a non-executive director of Marwyn Acquisition Company III
Limited and a director of Silvercloud Holdings Limited.

Dividend Policy

The Company has not yet acquired a trading business and it is therefore
inappropriate to make a forecast of the likelihood of any future dividends.
The Directors intend to determine the Company's dividend policy following
completion of an acquisition and, in any event, will only commence the payment
of dividends when it becomes commercially prudent to do so.

Key Performance Indicators

The Company has not yet acquired a trading business and therefore no key
performance indicators have been set as it is inappropriate to do so.

Stated Capital

Details of the share capital of the Company during the period are set out in
note 12 to the Financial Statements.

On 24 December 2021 the Company issued 700,000 ordinary shares and matching
warrants for a total price of £700,000. 90% of the ordinary shares and
matching warrants were issued to an entity managed by Marwyn Investment
Management LLP ("MIM LLP") and these are still held by this entity as at the
date of this report. The remaining 10% were issued to third party investors,
including a number of senior executive managers of previous successful
acquisition companies launched by Marwyn.

On 5 March 2023, pursuant to the forward purchase agreement ("FPA") with
Marwyn Value Investors II LP, the Company raised £600,000 through the issue
of 600,000 A shares ("A Shares") (with Class A Warrants ("A Warrants") being
issued on the basis of one Class A Warrant per A Share) at a price of £1 per
share. The A Shares are ordinary equity shares with the same economic rights
as the Company's ordinary shares but without voting rights. They are
convertible into ordinary shares on a one-for-one basis at the time at which
the Company next publishes a prospectus or equivalent document in relation to
a future listing of shares.

Corporate Governance

As a company with a Standard Listing, the Company is not required to comply
with the provisions of the UK Corporate Governance Code and given the size and
nature of the Group the Directors have decided not to adopt the UK Corporate
Governance Code. Nevertheless, the Board is committed to maintaining high
standards of corporate governance and will consider whether to voluntarily
adopt and comply with the UK Corporate Governance Code as part of any
acquisition, taking into account the Company's size and status at that time.

The Company currently complies with the following principles of the UK
Corporate Governance Code:

·      The Company is led by an effective and entrepreneurial board of
directors (''Board''), whose role is to promote the long term sustainable
success of the Company, generating value for shareholders and contributing to
wider society;

·      The Board ensures that it has the policies, processes,
information, time and resources it needs in order to function effectively and
efficiently; and

·      The Board ensures that the necessary resources are in place for
the Company to meet its objectives and measure performance against them.

Given the size and nature of the Company, the Board has not established any
committees and intends to make decisions as a whole. If the need should arise
in the future, for example following any acquisition, the Board may set up
committees and may decide to comply with the UK Corporate Governance Code.

Risks

A robust risk assessment was carried out by the Directors of the Company,
along with its advisers, in preparation for the Company's IPO on 24 December
2021 and the Directors have identified a wide range of risks, which are set
out in the Company's prospectus dated 24 December 2021. The risks relevant to
the Company are formally reviewed by the Board on at least an annual basis,
with more frequent updates being made as and when circumstances require. The
Company's prospectus is available on the Company's website: www.macalpha.com
(http://www.macalpha.com) .

The Company's risk management framework incorporates a risk assessment that
identifies and assesses the strategic, operational and financial risks facing
the business and mitigating controls. The risk assessment is documented
through a risk register which categorises the key risks faced by the business
into:

·      Business risks;

·      Shareholder risks;

·      Financial and procedural risks; and

·      Risks associated with the acquisition process.

The risk assessment identifies the potential impact and likelihood of each of
the risks detailed on the risk register and mitigating factors/actions have
also been identified.

The Company's risk management process includes both formal and informal
elements. The size of the Board and the frequency in which they interact
ensures that risks, or changes to the nature of the Company's existing risks,
are identified, discussed and analysed quickly. The Company has a formal
framework in place to manage the review, consideration and formal approval of
the risk register, including the risk assessment.

The Group's only significant asset is cash. As at the balance sheet date the
Group's cash balance was £554,446 (2022: £282,244). Price, credit, liquidity
and cashflow risk are not considered to be significant due to the simple
nature of the Company's assets and liabilities and the current activities
undertaken by the Group. As the Group's assets are predominantly cash and cash
equivalents, market risk, and liquidity risk are not currently considered to
be material risks to the Group. The Directors have reviewed the risk of
holding a singular concentration of assets as predominantly all credit assets
held are cash and cash equivalents, however, do not deem this a material risk.
The risk is mitigated by all cash and cash equivalents being held with
Barclays Bank plc, which holds a short-term credit rating of P-1, as issued by
Moody's. The Directors have set out below the principal risks faced by the
business. These are the risks the Directors consider to be most relevant to
the Company based on its current status. The risks referred to below do not
purport to be exhaustive and are not set out in any particular order of
priority.

 Key risk                                                                        Explanation
 The Company requires further funding to pursue its stated investment strategy.  The Company does not currently have sufficient cash to pursue its stated
                                                                                 investment strategy. On 16 December 2021, the Company entered into a FPA with
                                                                                 Marwyn Value Investors II LP and Marwyn General Partner II Limited, under
                                                                                 which the Company has the ability to drawdown up to £20 million, which may be
                                                                                 drawn down for working capital purposes and to fund due diligence on potential
                                                                                 acquisition targets, through the issue of unlisted A shares. Any drawdown
                                                                                 under the FPA is subject to the prior approval of Marwyn Investment Management
                                                                                 LLP (the manager of the Marwyn Fund) and the satisfaction of conditions
                                                                                 precedent.  On 5 March 2023, pursuant to the FPA the Company drew down
                                                                                 £600,000.
 The Company could incur costs for transactions that may ultimately be           There is a risk that the Company may incur substantial legal, financial and
 unsuccessful.                                                                   advisory expenses arising from unsuccessful transactions which may include
                                                                                 public offer and transaction documentation, legal, accounting and other due
                                                                                 diligence which could have a material adverse effect on the business,
                                                                                 financial condition, results of operations and prospects of the Company.
 The Company may not be able to complete an acquisition and may face             The Company's future success is dependent upon its ability to not only
 significant competition for acquisition opportunities.                          identify opportunities but also to execute a successful acquisition. There can

                                                                               be no assurance that the Company will be able to conclude agreements with any
                                                                                 target business and/or shareholders in the future and failure to do so could
                                                                                 result in the loss of an investor's investment. In addition, the Company may
                                                                                 not be able to raise the additional funds required to acquire any target
                                                                                 business, fund future operating expenses after the initial twelve months, or
                                                                                 incur the expense of due diligence for the pursuit of acquisition
                                                                                 opportunities in accordance with its investment objective.

                                                                                 There may also be significant competition for some, or all, of the acquisition
                                                                                 opportunities that the Company may explore. Such competition may for example
                                                                                 come from strategic buyers, sovereign wealth funds, special purpose
                                                                                 acquisition companies and public and private investment funds, many of which
                                                                                 are well established and have extensive experience in identifying and
                                                                                 completing acquisitions. A number of these competitors may possess greater
                                                                                 technical, financial, human and other resources than the Company. Therefore,
                                                                                 the Company may identify an investment opportunity in respect of which it
                                                                                 incurs costs, for example through due diligence and/or financing, but the
                                                                                 Company cannot assure investors that it will be successful against such
                                                                                 competition. Such competition may cause the Company to incur significant costs
                                                                                 but be unsuccessful in executing an acquisition.
 The success of the Company's investment objective is not guaranteed.            The Company's return will be reliant upon the performance of the assets
                                                                                 acquired and the Company's investment objective from time to time. The success
                                                                                 of the investment objective depends on the Directors' ability to identify
                                                                                 investments in accordance with the Company's strategy and to interpret market
                                                                                 data and predict market trends correctly. No assurance can be given that the
                                                                                 strategy to be used will be successful under all or any market conditions or
                                                                                 that the Company will be able to generate positive returns for shareholders.
                                                                                 If the investment objective is not successfully implemented, this could
                                                                                 adversely impact the business, development, financial condition, results of
                                                                                 operations and prospects of the Company.

Directors Interests

The Directors have no direct interests in the ordinary shares of the Company.
The Directors have interests in the Company's long term incentive plan, as
detailed in note 15 to the Financial Statements. James Corsellis is the
managing partner of Marwyn Investment Management LLP ("MIM LLP"), and
Antoinette Vanderpuije and Tom Basset are partners in MIM LLP which manages
95% per cent of the ordinary share capital and matching warrants and 100% of
the ordinary share capital and matching A warrants. James Corsellis is also
the managing partner of Marwyn Capital LLP ("MC LLP"), and Antoinette
Vanderpuije and Tom Basset are partners in MC LLP, a firm which provides
corporate finance, company secretarial and ad-hoc managed services support to
the Company.

Details of the related party transactions which occurred during the year are
disclosed in note 16 to the Financial Statements, save for the participation
in the Company's long term incentive plan as disclosed in note 15 to the
Financial Statements. There were no loans or guarantees granted or provided by
the Company and/or any of its subsidiaries to or for the benefit of any of the
Directors.

Statement of Going Concern

The Financial Statements are prepared on a going concern basis, which assumes
the Group will continue to be able to meet its liabilities as they fall due
for the foreseeable future. The Group had cash resources of £554,446 (2022:
£282,244) at 30 June 2023 and net assets of £502,011 (2022: £225,474). The
Directors have considered the financial position of the Group and reviewed
forecasts and budgets for a period of at least 12 months following the
approval of the Financial Statements.

On 16 December 2021, the Company entered into a forward purchase agreement
("FPA") with Marwyn Value Investors II LP (''MVI II LP'') of up to £20
million, which may be drawn for general working capital purposes and to fund
due diligence costs. Any drawdown is subject to the prior approval of MVI II
LP and the satisfaction of conditions precedent. On 5 March 2023, the Company
drew down £600,000 under the FPA and accordingly issued 600,000 A shares and
600,000 matching A warrants as set out in the FPA.

The Directors have reviewed the working capital model for the Group, which
includes the drawdown under the FPA, in detail and are satisfied that the
Company will have sufficient cash to meet its ongoing operating costs. Subject
to the structure of an acquisition, the Company will likely need to raise
additional funds for an acquisition in the form of equity and/or debt.

Based on this review the Directors are satisfied that at the date of approval
of the Financial Statements, the Company and the Group have sufficient
resources to continue to pursue its stated strategy.

Outlook

The Directors continue to identify and develop opportunities with potential
management partners, across a variety of sectors, and believe the listed
status and structure of the Company position it well to capitalise on these
opportunities in the current market environment.

RESPONSIBILTY STATEMENT

 

The Directors are responsible for preparing the Financial Statements in
accordance with applicable laws and regulations, including the BVI Business
Companies Act, 2004. The Directors have prepared the Financial Statements for
the year to 30 June 2023, which give a true and fair view of the state of
affairs of the Group and the profit or loss of the Group for that year.

The Directors have acted honestly and in good faith and in what the Directors
believe to be in the best interests of the Company.

The Directors have chosen to use International Financial Reporting Standards
as adopted by the European Union ("EU adopted IFRS" or "IFRS") in preparing
the Financial Statements. International Accounting Standard 1 requires that
financial statements present fairly for each financial period the group's
financial position, financial performance and cash flows. This requires the
faithful presentation of the effects of transactions, other events and
conditions in accordance with the definitions and recognition criteria for
assets, liabilities, income and expenses set out in the International
Accounting Standards Board's "Framework for the preparation and presentation
of financial statements". In virtually all circumstances, a fair presentation
will be achieved by compliance with all applicable IFRS.

A fair presentation also requires the Directors to:

·      select consistently and apply appropriate accounting policies;

·      present information, including accounting policies, in a manner
that provides relevant, reliable, comparable and understandable information;

·      make judgements and accounting estimates that are reasonable and
prudent;

·      provide additional disclosures when compliance with the specific
requirements in IFRS is insufficient to enable users to understand the impact
of particular transactions, other events and conditions on the entity's
financial position and financial performance;

·      state that the Group has complied with IFRS, subject to any
material departures disclosed and explained in the financial statements; and

·      prepare the financial statements on the going concern basis
unless it is inappropriate to presume that the company will continue in
business.

The Directors are also required to prepare financial statements in accordance
with the rules of the London Stock Exchange for companies trading securities
on the Stock Exchange.

The Directors are responsible for keeping proper accounting records which
disclose with reasonable accuracy at any time the financial position of the
Group, for safeguarding the assets, for taking reasonable steps for the
prevention and detection of fraud and other irregularities and for the
preparation of financial statements.

Financial information is published on the Group's website. The maintenance and
integrity of this website is the responsibility of the Directors; the work
carried out by the auditor does not involve consideration of these matters
and, accordingly, the auditor accepts no responsibility for any changes that
may occur to the financial statements after they are presented initially on
the website. Legislation in the British Virgin Islands governing the
preparation and dissemination of financial statements may differ from
legislation in other jurisdictions.

Directors' Responsibilities Pursuant to DTR4

In compliance with the Listing Rules of the London Stock Exchange, the
Directors confirm to the best of their knowledge:

· The Financial Statements have been prepared in accordance with IFRS and
give a true and fair view of the assets, liabilities, financial position and
loss of the Group; and

· The management report includes a fair review of the development and
performance of the business and the financial position of the Group, together
with a description of the principal risks and uncertainties that it faces.

Independent Auditor

Baker Tilly Channel Islands Limited ("BTCI") remains the Company's independent
auditor for the year ended 30 June 2023 and has expressed its willingness to
continue to act as auditor to the Group.

Disclosure of Information to Auditor

Each of the Directors in office at the date the Report of the Directors is
approved, whose names and functions are listed in the Report of the Directors
confirm that, to the best of their knowledge:

·      the Financial Statements, which have been prepared in accordance
with EU adopted IFRS, present fairly the assets, liabilities, financial
position and loss of the Group;

·      the Report of the Directors includes a fair review of the
development and performance of the business and the position of the Group and
Company, together with a description of the principal risks and uncertainties
that it faces;

·      so far as they are aware, there is no relevant audit information
of which the Group's auditor is unaware; and

·      they have taken all the steps that they ought to have taken as a
Director in order to make themself aware of any relevant audit information and
to establish that the Group's auditor is aware of that information.

 

This Directors' Report was approved by the Board of Directors on 9 October
2023 and is signed on its behalf.

 

By Order of the Board

 

 

James Corsellis
Chairman

9 October 2023

INDEPENDENT AUDITOR'S REPORT

 

INDEPENDENT AUDITOR'S REPORT TO THE MEMBERS OF MAC ALPHA LIMITED

Opinion

We have audited the consolidated financial statements of MAC Alpha Limited
(the "Company" and, together with its subsidiary, MAC Alpha (BVI) Limited, the
"Group"), which comprise the consolidated statement of financial position as
at 30 June 2023, and the consolidated statement of comprehensive income,
consolidated statement of changes in equity and consolidated statement of cash
flows for the year then ended, and notes to the consolidated financial
statements, including a summary of significant accounting policies.

In our opinion, the accompanying consolidated financial statements:

·      give a true and fair view of the consolidated financial position
of the Group as at 30 June 2023, and of its consolidated financial performance
and its consolidated cash flows for the year then ended in accordance with
International Financial Reporting Standards as adopted by the European Union
(IFRSs); and

·      have been prepared in accordance with the requirements of the BVI
Business Company Act 2004, as amended.

Basis for Opinion

We conducted our audit in accordance with International Standards on Auditing
(UK) (ISAs) and applicable law. Our responsibilities under those standards are
further described in the Auditor's Responsibilities for the Audit of the
Consolidated Financial Statements section of our report. We are independent of
the Group in accordance with the ethical requirements that are relevant to our
audit of the consolidated financial statements in Jersey, including the FRC's
Ethical Standard, and we have fulfilled our other ethical responsibilities in
accordance with these requirements. We believe that the audit evidence we have
obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgement, were
of most significance in our audit of the consolidated financial statements of
the current period and include the most significant assessed risks of material
misstatement (whether or not due to fraud) identified by us, including those
which had the greatest effect on: the overall audit strategy; the allocation
of resources in the audit; and directing the efforts of the engagement team.
These matters were addressed in the context of our audit of the consolidated
financial statements as a whole, and in forming our opinion thereon, and we do
not provide a separate opinion on these matters.

 Key audit matter                                                                 How our audit addressed the matter                                               Key observations communicated to those charged with governance
 Equity and Warrants Issuance                                                     Classification                                                                   Based on the procedures performed, we are satisfied that management's

                                                                                judgements and estimates in respect of the valuation and classification of
 The warrants issued to investors are subject to judgement in both                We obtained an understanding of management's assessment for the classification   warrants for the year ended 30 June 2023, along with the related disclosures
 classification and valuation.                                                    of these instruments and the rationale for their classification.                 in the consolidation financial statements, are appropriate.

 The classification of the warrants is complex and must consider the nature and   We reviewed, in conjunction with our Technical Director the classification of    We have nothing to report to those charged with governance from our testing.
 details of the instrument contracts to determine the correct classification      these instruments and management's assessment in accordance with IAS 32 and
 between equity and liabilities.                                                  IFRS 9 and we challenged management on their assessment.

 Further the fair value of these warrants was determined using the Black          Valuation
 Scholes option pricing methodology which considered the exercise price,

 expected volatility, risk free rate, expected dividends and expected term of     We obtained the valuation report prepared by management's expert and reviewed
 the warrants which is complex and involves estimates and judgements.             the credentials and inputs used.

 Financial statement impact: £207,000 (PY: 105,000).                              We performed the review of and validation of the valuation assumptions,

                                                                                methodology and calculations in respect of the valuation of the instruments
 The accounting policies on pages 21 and 22 sets out the treatment applied by     and determined whether it was in accordance with the requirements of IFRS 9
 management, and related disclosures are presented in note 12.                    and IFRS 13.

                                                                                  Disclosure

                                                                                  We reviewed the relevant disclosures in the consolidated financial statements
                                                                                  in accordance with the requirements of the IFRS as adopted by the European
                                                                                  Union and performed a financial statement disclosure checklist utilising
                                                                                  specialist software.

 

Our Application of Materiality

Materiality for the consolidated financial statements as a whole was set at
£20,000 (PY: £5,600), determined with reference to a benchmark of net
assets, of which it represents 4% (PY: 2.5%).

In line with our audit methodology, our procedures on individual account
balances and disclosures were performed to a lower threshold, performance
materiality, so as to reduce to an acceptable level the risk that individually
immaterial misstatements in individual account balances add up to a material
amount across the consolidated financial statements as a whole.

Performance materiality was set at 70% (PY: 70%) of materiality for the
consolidated financial statements as a whole, which equates to £14,000 (PY:
£3,950). We applied this percentage in our determination of performance
materiality because we did not identify any factors indicating an elevated
level of risk.

We reported to the Audit Committee any uncorrected omissions or misstatements
exceeding £1,000 (PY: £282), in addition to those that warranted reporting
on qualitative grounds.

The work on all the components was performed by the Group audit team.

Conclusions relating to Going Concern

In auditing the consolidated financial statements, we have concluded that the
Directors' use of the going concern basis of accounting in the preparation of
the consolidated financial statements is appropriate.

Based on the work we have performed, we have not identified any material
uncertainties relating to events or conditions that, individually or
collectively, may cast significant doubt on the Group and Company's ability to
continue as a going concern for a period of at least twelve months from when
the consolidated financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Directors with respect to
going concern are described in the relevant sections of this report.

Other Information

The other information comprises the information included in the annual report
other than the consolidated financial statements and our auditor's report
thereon. The Directors are responsible for the other information contained
within the annual report. Our opinion on the consolidated financial statements
does not cover the other information and, except to the extent otherwise
explicitly stated in our report, we do not express any form of assurance
conclusion thereon. Our responsibility is to read the other information and,
in doing so, consider whether the other information is materially inconsistent
with the consolidated financial statements or our knowledge obtained in the
course of the audit, or otherwise appears to be materially misstated. If we
identify such material inconsistencies or apparent material misstatements, we
are required to determine whether this gives rise to a material misstatement
in the consolidated financial statements themselves. If, based on the work
performed, we conclude that there is a material misstatement of this other
information, we are required to report that fact.

We have nothing to report in this regard.

Responsibilities of the Directors

As explained more fully in the Directors' responsibilities statement set out
on page 8 and 9, the Directors are responsible for the preparation of
consolidated financial statements that give a true and fair view in accordance
with IFRSs, and for such internal control as the Directors determine is
necessary to enable the preparation of consolidated financial statements that
are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, the Directors are
responsible for assessing the Group's ability to continue as a going concern,
disclosing, as applicable, matters related to going concern and using the
going concern basis of accounting unless management either intends to
liquidate the Company or to cease operations, or has no realistic alternative
but to do so.

The Directors are responsible for overseeing the Group's financial reporting
process.

Auditor's Responsibilities for the Audit of the Consolidated Financial
Statements

Our objectives are to obtain reasonable assurance about whether the
consolidated financial statements as a whole are free from material
misstatement, whether due to fraud or error, and to issue an auditor's report
that includes our opinion. Reasonable assurance is a high level of assurance,
but is not a guarantee that an audit conducted in accordance with ISAs will
always detect a material misstatement when it exists. Misstatements can arise
from fraud or error and are considered material if, individually or in the
aggregate, they could reasonably be expected to influence the economic
decisions of users taken on the basis of these consolidated financial
statements.

The extent to which our procedures are capable of detecting irregularities,
including fraud, is detailed below:

·      Enquiry of management to identify any instances of non-compliance
with laws and regulations, including actual, suspected or alleged fraud;

·      Reading minutes of meetings of the Board of Directors;

·      Review of legal invoices;

·      Review of management's significant estimates and judgements for
evidence of bias;

·      Review for undisclosed related party transactions;

·      Using analytical procedures to identify any unusual or unexpected
relationships; and

·      Undertaking journal testing, including an analysis of manual
journal entries to assess whether there were large and/or unusual entries
pointing to irregularities, including fraud.

The Company is required to include these financial statements in an annual
financial report prepared using the single electronic reporting format
specified in the TD ESEF Regulation. The auditor's report provides no
assurance over whether the annual financial report has been prepared in
accordance with that format.

A further description of the auditor's responsibilities for the audit of the
financial statements is located at the Financial Reporting Council's website
at www.frc.org.uk/auditorsresponsibilities.

This description forms part of our auditor's report.

Other Matters which we are Required to Address

We were appointed by MAC Alpha Limited to audit the consolidated financial
statements. Our total uninterrupted period of engagement is 2 years.

The non-audit services prohibited by the FRC's Ethical Standard were not
provided to the Group and we remain independent of the Group in conducting our
audit. Our audit opinion is consistent with the additional report to the audit
committee in accordance with ISAs.

Use of this Report

This report is made solely to the Members of the Company, as a body, in
accordance with our letter of engagement dated 5 September 2023. Our audit
work has been undertaken so that we might state to the Members those matters
we are required to state to them in an auditor's report and for no other
purpose. To the fullest extent permitted by law, we do not accept or assume
responsibility to anyone other than the Company and its Members, as a body,
for our audit work, for this report, or for the opinions we have formed.

 

Sandy Cameron

For and on behalf of Baker Tilly Channel Islands Limited

Chartered Accountants

St Helier, Jersey

Date: 9 October 2023

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

 

                                                       Year ended      Period ended

                                                       30 June         30 June

                                                       2023            2022
                                                 Note  £'s             £'s

 Administrative expenses                         6     (331,885)       (266,043)
 Total operating loss                                  (331,885)       (266,043)

 Finance income                                        8,422           -
 Loss before income taxes                              (323,463)       (266,043)

 Income tax                                            -               -
 Loss for the year / period                            (323,463)       (266,043)
 Total other comprehensive income                      -               -
 Total comprehensive loss for the year / period        (323,463)       (266,043)

 Loss per ordinary share                               £'s             £'s
 Basic and diluted                               7      (0.3625)       (0.5297)

 

The Group's activities derive from continuing operations.

The notes on pages 19 to 31 form an integral part of these Financial
Statements.

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

 

                                       As at              As at

                                       30 June 2023       30 June 2022
 Assets                        Note    £'s                £'s

 Current assets
 Other receivables             9       6,621              9,602
 Cash and cash equivalents     10      554,446            282,244
 Total current assets                  561,067            291,846

 Total assets                          561,067            291,846

 Equity and liabilities

 Equity
 Ordinary shares               12      319,000            319,000
 A shares                      12      498,000            -
 Sponsor share                 12      1                  1
 Warrant reserve               12, 13  105,000            105,000
 Warrant reserve A shares      12, 13  102,000            -
 Share-based payment reserve   13, 15  67,516             67,516
 Accumulated losses            13      (589,506)          (266,043)
 Total equity                          502,011            225,474

 Current liabilities
 Trade and other payables      11      59,056             66,372
 Total liabilities                     59,056             66,372

 Total equity and liabilities          561,067            291,846

 

The notes on pages 19 to 31 form an integral part of these Financial
Statements.

The Financial Statements were issued and approved by the Board of Directors on
9 October 2023 and were signed on its behalf by:

 

 

 

 

 James Corsellis  Tom Basset

 Chairman         Non-Executive Director

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

 

                                                            Ordinary shares  A shares  Sponsor share  Warrant reserve                             Share based payment reserve  Accumulated losses  Total equity

                                                                                                                       Warrant reserve A shares
                                                            £'s              £'s       £'s            £'s              £'s                        £'s                          £'s                 £'s
 Balance at incorporation                                   -                -         -              -                -                          -                            -                   -
 Issuance of 1 ordinary share                               1                -         -              -                -                          -                            -                   1
 Redesignation of 1 ordinary share                          (1)              -         1              -                -                          -                            -                   -
 Issuance of 700,000 ordinary shares and matching warrants  595,000          -         -              105,000          -                          -                            -                   700,000
 Share issue costs                                          (276,000)        -         -              -                -                          -                            -                   (276,000)
 Total comprehensive loss for the period                    -                -         -              -                -                          -                            (266,043)           (266,043)
 Share-based payment charge                                 -                -         -              -                -                          67,516                       -                   67,516
 Balance at 30 June 2022                                    319,000          -         1              105,000          -                          67,516                       (266,043)           225,474

 

                                                     Ordinary shares  A shares  Sponsor share  Warrant reserve                             Share based payment reserve  Accumulated losses  Total equity

                                                                                                                Warrant reserve A shares
                                                     £'s              £'s       £'s            £'s              £'s                        £'s                          £'s                 £'s
 Balance at 1 July 2023                              319,000          -         1              105,000          -                          67,516                        (266,043)          225,474
 Issuance of 600,000 A shares and matching warrants  -                498,000   -              -                102,000                    -                            -                   600,000
 Total comprehensive loss for the year               -                -         -              -                -                          -                            (323,463)           (323,463)
 Balance at 30 June 2023                             319,000          498,000   1              105,000          102,000                    67,516                        (589,506)          502,011

 

The notes on pages 19 to 31 form an integral part of these Financial
Statements.

 

CONSOLIDATED STATEMENT OF CASH FLOWS

 

                                                                                      Year ended      Period ended

                                                                                      30 June         30 June
                                                                                2023                  2022
                                                                                Note  £'s             £'s
 Operating activities
 Loss for the year / period                                                           (323,463)       (266,043)

 Adjustments to reconcile total operating loss to net cash flows:
 Finance income                                                                       (8,422)         -
 Share-based payment expense                                                    15    -               52,516
 Working capital adjustments:
 Decrease / (Increase) in other receivables                                           2,981           (9,602)
 (Decrease) / Increase in trade and other payables                                     (7,316)        66,372

 Net cash flows used in operating activities                                          (336,220)       (156,757)

 Investing activities
 Interest received                                                                    8,422           -
 Net cash flows received from investing activities                                    8,422

 Financing activities
 Proceeds from issue of A shares and matching A warrants                        12    600,000         -
 Proceeds from issue of ordinary shares, matching warrants and 1 sponsor share  12    -               700,001
 Proceeds from issue of incentive shares                                        15    -               15,000
 Costs directly attributable to equity raise                                    12    -               (276,000)
 Net cash flows received from financing activities                                    600,000         439,001

 Net increase in cash and cash equivalents                                            272,202         282,244
 Cash and cash equivalents at the beginning of the year / period                      282,244         -
 Cash and cash equivalents at the end of the year / period                      10     554,446        282,244

 

The notes on pages 19 to 31 form an integral part of these Financial
Statements.

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

 

1.   GENERAL INFORMATION

MAC Alpha Limited was incorporated on 11 October 2021 in the British Virgin
Islands ("BVI") as a BVI business company (registered number 2078235) under
the BVI Business Company Act, 2004. The Company was listed on the Main Market
of the London Stock Exchange on 24 December 2021 and has its registered
address at Commerce House, Wickhams Cay 1, P.O. Box 3140, Road Town, Tortola,
VG1110, British Virgin Islands.

The Company has been formed for the purpose of effecting a merger, share
exchange, asset acquisition, share or debt purchase, reorganisation or similar
business combination with one or more businesses. The Company has one
subsidiary, MAC Alpha (BVI) Limited (together with the Company the "Group").

 

2.   ACCOUNTING POLICIES

(a)    Basis of preparation

The Financial Statements for the year ended 30 June 2023 have been prepared in
accordance with International Financial Reporting Standards and IFRS
Interpretations Committee interpretations as adopted by the European Union
(collectively, "EU adopted IFRS" or "IFRS") and are presented in British
pounds sterling, which is the presentational currency of the Group and the
functional currency and presentational currency of the Company.

The Financial Statements have been prepared under the historical cost basis.
The comparative reporting period represents the period from incorporation,
being 11 October 2021, to 30 June 2022 and accordingly the periods are not
directly comparable.

The principal accounting policies adopted in the preparation of the Financial
Statements are set out below. The policies have been consistently applied
throughout the period presented.

(b)   Going concern

The Financial Statements are prepared on a going concern basis, which assumes
the Group will continue to be able to meet its liabilities as they fall due
for the foreseeable future. The Group had cash resources of £554,446 (2022:
£282,244) at 30 June 2023 and net assets of £502,011 (2022: £225,474). The
Directors have considered the financial position of the Group and reviewed
forecasts and budgets for a period of at least 12 months following the
approval of the Financial Statements.

On 16 December 2021, the Company entered into a forward purchase agreement
("FPA") with Marwyn Value Investors II LP (''MVI II LP'') of up to £20
million, which may be drawn for general working capital purposes and to fund
due diligence costs. Any drawdown is subject to the prior approval of MVI II
LP and the satisfaction of conditions precedent. On 5 March 2023, the Company
drew down £600,000 under the FPA and accordingly issued 600,000 A shares and
600,000 matching A warrants as set out in the FPA.

The Directors have reviewed the working capital model for the Group, which
includes the drawdown under the FPA, in detail and are satisfied that the
Company and the Group will have sufficient cash to meet its ongoing operating
costs. Subject to the structure of an acquisition, the Company will likely
need to raise additional funds for an acquisition in the form of equity and/or
debt.

Based on this review the Directors are satisfied that at the date of approval
of the Financial Statements, the Company and the Group have sufficient
resources to continue to pursue its stated strategy.

(c)    New standards and amendments to International Financial Reporting
Standards

Standards, amendments and interpretations issued but not yet effective:

The following standards are issued but not yet effective. The Group intends to
adopt these standards, if applicable, when they become effective. It is not
currently expected that these standards will have a material impact on the
Group.

 

 Standard                                                                       Effective date
 Extension of temporary exemption of applying IFRS 9 (Amendments to IFRS 4);    1 January 2023
 Amendments to IFRS 17 Insurance contracts;                                     1 January 2023
 Disclosure of accounting policies (Amendments to IAS 1);                       1 January 2023
 Definition of accounting estimates (Amendments to IAS 8);                      1 January 2023
 Deferred Tax relating to Assets and Liabilities arising from a Single          1 January 2023
 Transaction (Amendments to IAS 12);
 International Tax Reform - Pillar Two Model Rules (Amendments to IAS 12);      1 January 2023
 Initial Application of IFRS 17 and IFRS 9 - Comparative Information Amendment  1 January 2023
 to IFRS 17);
 Supplier Finance Arrangements (Amendments to IAS 7 and IFRS 7)*;               1 January 2024
 Non-current Liabilities with Covenants (Amendments to IAS 1);                  1 January 2024
 Amendment to IFRS 16 Leases: Lease Liability in a sale & leaseback;            1 January 2024
 Amendments to IAS 1 Presentation of Financial Statements: Classification of    1 January 2024
 Liabilities as Current or Non-current*;and
 Amendments to IAS 21 Lack of exchangeability.                                  1 January 2025
 * Subject to EU endorsement

(d)   Basis of consolidation

Subsidiaries are entities controlled by the Company. Control exists when the
Company is exposed to, or has rights to, variable returns from its involvement
with the entity and has the ability to affect those returns through its power
over the entity. The financial information of subsidiaries is fully
consolidated in these Financial Statements from the date that control
commences until the date that control ceases.

Intragroup balances, and any gains and losses or income and expenses arising
from intragroup transactions, are eliminated in preparing these Financial
Statements.

(e)   Financial instruments

A financial instrument is any contract that gives rise to a financial asset of
one entity and a financial liability or equity instrument of another entity.

(f)    Cash and cash equivalents

Cash and cash equivalents comprise cash balances at banks.

(g)   Stated capital

Ordinary shares, A shares and sponsor shares are classified as equity.
Incremental costs directly attributable to the issue of new shares are
recognised in equity as a deduction from the proceeds.

(h)   Corporation tax

There is no corporate, income or other tax of the British Virgin Islands
imposed by withholding or otherwise on BVI companies. The Company will
therefore not have any tax liabilities or deferred tax in the BVI. The Company
is exempt from all provisions of the Income Tax Act of the British Virgin
Islands.

(i)    Loss per ordinary share

The Group presents basic earnings per ordinary share ("EPS") data for its
ordinary shares.  Basic EPS is calculated by dividing the profit or loss
attributable to ordinary shareholders of the Company by the weighted average
number of ordinary shares outstanding during the period. Diluted EPS is
calculated by adjusting the weighted average number of ordinary shares
outstanding to assume conversion of all potential dilutive ordinary shares.

(j)    Share based payments

The A ordinary shares in MAC Alpha (BVI) Limited (the "Incentive Shares"),
represent equity-settled share-based payment arrangements under which the
Company receives services as a consideration for the additional rights
attached to these equity shares, over and above their nominal price.

Equity-settled share-based payments to Directors and others providing similar
services are measured at the fair value of the equity instruments at the grant
date. Fair value is determined using an appropriate valuation technique,
further details of which are given in note 15. The fair value is expensed,
with a corresponding increase in equity, on a straight-line basis from the
grant date to the expected exercise date. Where the equity instruments granted
are considered to vest immediately, the services are deemed to have been
received in full, with a corresponding expense and increase in equity
recognised at grant date.

(k)   Warrants

The Company has issued Ordinary shares and with matching warrants and A shares
and with matching A Warrants. Under the terms of the warrant instruments,
warrant holders are able to acquire one corresponding share per warrant at a
price of £1 per share. Warrants are accounted for as equity instruments under
IAS 32 and are measured at fair value at grant date. Fair value of the
warrants has been calculated using a Black Scholes option pricing methodology
and details of these estimates and judgements used in determining fair value
of the warrants are set out in note 3.

3.    CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION
UNCERTAINTY

The preparation of the Group's Financial Statements under IFRS requires the
Directors to make estimates and assumptions that affect the reported amounts
of assets and liabilities and the disclosure of contingent assets and
liabilities. Estimates and judgements are continually evaluated and are based
on historical experience and other factors including expectations of future
events that are believed to be reasonable under the circumstances. Actual
results may differ from these estimates.

Critical accounting judgements

Classification of warrants

On 24 December 2021, the Company issued 700,000 ordinary shares and matching
warrants ("Warrants"). Under the terms of the warrant instrument, warrant
holders are able to acquire one ordinary share per warrant at a price of £1
per ordinary share. The Warrants are exercisable at any time until five years
after the IPO date, being 24 December 2021. Further on 5 March 2023, the
Company issued 600,000 A shares and matching Class A Warrants ("A Warrants")
being issued on the basis of one Class A Warrant per A Share at a price of £1
per share. The Warrants are exercisable at any time until five years after the
IPO date being 24 December 2021.

The Warrants and A Warrants can only be classified as equity if they will be
settled only by the issuer exchanging a fixed amount of cash or another
financial asset for a fixed number of its own equity instruments. The warrant
instruments contain an exercise price adjustment ("Exercise Price
Adjustment"), whereby if the corresponding shares are issued at less than £1
before or as part of an acquisition then the exercise price equals the
discounted issue price, as a result the fixed-for-fixed requirement is
breached. However, it is the opinion of the Directors that whilst the Exercise
Price Adjustment exists, the likelihood of this being used is remote, and
therefore it is most appropriate for the warrants and A Warrants to be
classified as equity.

Key sources of estimation uncertainty

Valuation of incentive shares

There are significant estimates and assumptions used in the valuation of the
Incentive Shares. Management has considered at the grant date, the probability
of a successful first acquisition by the Group and the potential range of
value for the Incentive Shares, based on the circumstances on the grant date.
The fair value of the Incentive Shares and related share-based payment expense
was calculated using a Monte Carlo valuation model. A summary of the terms is
set out in note 15.

Valuation of warrants

The Warrants were valued using the Black Scholes option pricing methodology
which considered the exercise price, expected volatility, risk free rate,
expected dividends and expected term of the Warrants.

 

4.    SEGMENT INFORMATION

The Board of Directors is the Group's chief operating decision-maker. As the
Group has not yet acquired an operating business, the Board of Directors
considers the Group as a whole for the purposes of assessing performance and
allocating resources, and therefore the Group has one reportable operating
segment.

 

5.    EMPLOYEES AND DIRECTORS

The Group does not have any employees. During the year ended 30 June 2023, the
Company had four serving directors as detailed on page 3, no director received
remuneration under the terms of their director service agreements (2022: 2
directors and £nil). The Company's subsidiary has issued Incentive Shares as
more fully disclosed in note 15 in which the Directors are indirectly
beneficially interested.

 

6.    ADMINISTRATIVE EXPENSES

                                                                    Year ended      Period ended

                                                                    30 June         30 June

                                                                    2023            2022
                                                                    £'s             £'s
 Group expenses by nature
 Professional support                                               288,477         131,842
 Non-recurring project, professional and due diligence costs        15,798          61,872
 Audit fees payable in respect of the audit of the Group (Note 18)  18,094          15,351
 Share-based payment expenses (Note 15)                             -               52,516
 Other expenses                                                     9,516           4,462
                                                                    331,885         266,043

 

7.    LOSS PER ORDINARY SHARE

Basic EPS is calculated by dividing the profit/ loss attributable to equity
holders of the company by the weighted average number of ordinary shares in
issue during the period. Diluted EPS is calculated by adjusting the weighted
average number of ordinary shares outstanding to assume conversion of all
dilutive potential ordinary shares. The weighted average number of shares has
not been adjusted in calculating diluted EPS as there are no instruments which
have a current dilutive effect.

The Company maintains different share classes, of which ordinary shares, A
shares and sponsor shares were in issue in the current year, and ordinary
shares and sponsor shares were in issue in the prior period. The key
difference between ordinary shares and A shares is that the ordinary shares
are traded with voting rights attached and the A shares are not listed and do
not carry voting rights. The ordinary share and A share classes both have
equal rights to the residual net assets of the Company, which enables them to
be considered collectively as one class per the provisions of IAS 33.

The sponsor share has no distribution rights so has been ignored for the
purposes of IAS 33.

Refer to note 15 (share based payments) for instruments that could potentially
dilute basic EPS in the future.

                                                   Year ended    Period ended

                                                   30 June       30 June

                                                   2023          2022
 Loss attributable to owners of the parent (£'s)   (323,463)     (266,043)
 Weighted average in issue                         892,329       502,290
 Basic and diluted loss per ordinary share (£'s)   (0.3625)      (0.5297)

 

8.    INVESTMENTS

Principal subsidiary undertakings of the Group

The Company owns directly the whole of the issued ordinary share capital of
its subsidiary undertaking. Details of the Company's subsidiary are presented
below:

                          Nature of business   Country of incorporation  Proportion of ordinary shares held by parent  Proportion of ordinary shares held by the Group

 Subsidiary

 MAC Alpha (BVI) Limited   Incentive vehicle   BVI                       100%                                          100%

The share capital of MAC Alpha (BVI) Limited consists of both ordinary shares
and A ordinary shares (the "Incentive Shares"). The Incentive shares are held
by Marwyn Long Term Incentive LP (''MLTI'') and are non-voting. Further detail
on the Incentive Shares is given in note 15.

The registered office of MAC Alpha (BVI) Limited is Commerce House, Wickhams
Cay 1, P.O. Box 3140, Road Town, Tortola, VG1110, British Virgin Islands.

 

9.    OTHER RECEIVABLES

                                      As at         As at

30 June
                                      30 June
2022

                                      2023
                                      £'s           £'s
 Amounts receivable within one year:
 Prepayments                          6,621         9,602
                                      6,621         9,602

There is no material difference between the book value and the fair value of
the receivables. Receivables are considered to be past due once they have
passed their contracted due date. Other receivables are all current.

 

10.  CASH AND CASH EQUIVALENTS

                            As at       As at

30 June
30 June

2023
2022
                            £'s         £'s
 Cash and cash equivalents
 Cash at bank               554,446     282,244
                            554,446     282,244

Credit risk is managed on a group basis. Credit risk arises from cash and cash
equivalents and deposits with banks and financial institutions. For banks and
financial institutions, only independently rated parties with a minimum
short-term credit rating of P-1, as issued by Moody's, are accepted.

 

11.  TRADE AND OTHER PAYABLES

                                                                                                                         As at       As at

30 June
30 June

2023
2022
                                                                                                                         £'s         £'s
 Amounts falling due within one year:
 Trade payables                                                                                                          5,430       3,258
 Accruals                                                                                                                42,116      31,625
 Due to a related party (Note 16)                                                                                        11,510      31,489
                                                                                                                         59,056      66,372

There is no material difference between the book value and the fair value of
the trade and other payables. All trade payables are non-interest bearing and
are usually paid within 30 days.

 

12.  STATED CAPITAL

 Authorised
 Unlimited ordinary shares of no par value
 Unlimited A shares of no par value
 Unlimited B shares of no par value
 100 sponsor shares of no par value

                                            As at         As at

                                            30 June       30 June

                                            2023          2022
                                            £'s           £'s
 Issued and fully paid
 700,000 ordinary shares of no par value    319,000       319,000
 600,000 A shares of no par value           498,000       -
 1 sponsor share of no par value            1             1

 

On incorporation, the Company issued 1 ordinary share of no par value to MVI
II Holdings I LP. On 28 October 2021, it was resolved that updated memorandum
and articles ("Updated M&A") be adopted by the Company and with effect
from the time the Updated M&A be registered with the Registrar of
Corporate Affairs in the British Virgin Islands, the 1 ordinary share which
was in issue by the Company be redesignated as 1 sponsor share of no par value
(the "Sponsor Share").

On 24 December 2021, the Company issued 700,000 ordinary shares and matching
warrants at a price of £1 for one ordinary share and matching Warrant. Under
the terms of the warrant instrument, warrant holders are able to acquire one
ordinary share per warrant at a price of £1 per ordinary share. Warrants are
accounted for as equity instruments under IAS 32 and are measured at fair
value at grant date, the combined market value of one

ordinary share and one warrant was considered to be £1, in line with the
market price paid by third party investors. A Black Scholes option pricing
methodology was used to determine the fair value of the Warrants, which
considered the exercise price, expected volatility, risk free rate, expected
dividends and expected term. Warrants have been assigned a fair value of 15p
per Warrant and each ordinary share has been valued at 85p per share,
therefore, on issuance of the Warrants £105,000 was recorded in the warrant
reserve. Costs of £276,000 directly attributable to the equity raise were
taken against stated capital at the issuance date.

On 5 March 2023, the Company issued 600,000 A shares and matching A Warrants
at a price of £1 for one A share and matching A Warrant. Under the terms of
the warrant instrument, warrant holders are able to acquire one A share per
warrant at a price of £1 per A share. A Warrants are accounted for as equity
instruments under IAS 32 and are measured at fair value at grant date, the
combined market value of one A share and one A Warrant was considered to be
£1, in line with the market price paid by third party investors. A Black
Scholes option pricing methodology was used to determine the fair value of the
A Warrants, which considered the exercise price, expected volatility, risk
free rate, expected dividends and expected term. A Warrants have been assigned
a fair value of 17p per A Warrant and each A share has been valued at 83p per
share, therefore, on issuance of the Warrants £102,000 was recorded in the
warrant reserve. There were no costs directly attributable to the issue of
shares.

Holders of ordinary shares are entitled to receive notice and attend and vote
at any meeting of members and have the right to a share in any distribution
paid by the Company and a right to a share in the distribution of the surplus
assets of the Company on a winding up. The A Shares are ordinary equity shares
with the same economic rights as the Company's ordinary shares but without
voting rights.

The Sponsor Share confers upon the holder no right to receive notice and
attend and vote at any meeting of members, no right to any distribution paid
by the Company and no right to a share in the distribution of the surplus
assets of the Company on a winding up. Provided the holder of the Sponsor
Share holds directly or indirectly 5 per cent or more of the issued and
outstanding shares of the Company (of whatever class other than any Sponsor
Shares), they have the right to appoint one director to the Board.

Provided the holder of the Sponsor Share holds directly or indirectly 5 per
cent. or more of the issued and outstanding shares of the Company (of whatever
class other than any Sponsor Shares) or is a holder of incentive shares the
Company must receive the prior consent of the holder of the Sponsor Share in
order to:

i.      issue any further Sponsor Shares;

ii.     issue any class of shares on a non pre-emptive basis where the
Company would be required to issue such share pre-emptively if it were
incorporated under the UK Companies Act 2006 and acting in accordance with the
Pre-Emption Group's Statement of Principles; or

iii.    amend, alter, or repeal any existing, or introduce any new
share-based compensation or incentive scheme in respect of the Group; and

iv.    take any action that would not be permitted (or would only be
permitted after an affirmative shareholder vote) if the Company were admitted
to the Premium Segment of the Official List.

The holder of the Sponsor Share has the right to require that: (i) any
purchase or redemption by the Company of its shares; or (ii) the Company's
ability to amend the Memorandum and Articles, be subject to a special
resolution of members whilst the Sponsor (or an individual holder of a Sponsor
Share) holds directly or indirectly 5 per cent or more of the issued and
outstanding shares of the Company (of whatever class other than any Sponsor
Shares) or are a holder of incentive shares.

 

13.  RESERVES

The following describes the nature and purpose of each reserve within
shareholders' equity:

Accumulated losses

Cumulative losses recognised in the Consolidated Statement of Comprehensive
Income.

Share based payment reserve

The share-based payment reserve is the cumulative amount recognised in
relation to the equity-settled share based payment scheme as further described
in note 15.

Warrant reserve

The warrant reserve is the cumulative fair value attributed to warrants issued
attached to ordinary shares.

Warrant reserve A shares

The warrant reserve is the cumulative fair value attributed to warrants issued
attached to A shares.

 

14.  FINANCIAL INSTRUMENTS AND ASSOCIATED RISKS

The Group has the following categories of financial instruments:

                                                     As at       As at

30 June
30 June

2023
2022
                                                     £'s         £'s
 Financial assets measured at amortised cost
 Cash and cash equivalents (Note 10)                 554,446     282,244
                                                     554,446     282,244

 Financial liabilities measured at amortised cost
 Trade and other payables (Note 11)                  47,546      66,372
 Due to a related party (Note 16)                    11,510      -
                                                     59,056      66,372

The fair value and book value of the financial assets and liabilities are
materially equivalent.

The Group's risk management policies are established to identify and analyse
the risks faced by the Group, to set appropriate risk limits and controls, and
to monitor risks and adherence limits. Risk management policies and systems
are reviewed regularly to reflect changes in market conditions and the Group's
activities.

Treasury activities are managed on a Group basis under policies and procedures
approved and monitored by the Board. These are designed to reduce the
financial risks faced by the Group which primarily relate to movements in
interest rates.

As the Group's assets are predominantly cash and cash equivalents, market risk
and liquidity risk are not currently considered to be material risks to the
Group.

 

15.  SHARE-BASED PAYMENTS

Management Long Term Incentive Arrangements

The Group has put in place a Long-Term Incentive Plan ("LTIP"), to ensure
alignment between Shareholders, and those responsible for delivering the
Company's strategy and attract and retain the best executive management
talent.

The LTIP will only reward the participants if shareholder value is created.
This ensures alignment of the interests of management directly with those of
Shareholders. As at the balance sheet date, an executive management team is
not yet in place and as such Marwyn Long Term Incentive LP ("MLTI") is the
only participant in the LTIP.  Any future issuances of Incentive Shares to
management will be dilutive to MLTI. Under the LTIP, Incentive Shares are
issued by MAC Alpha (BVI) Limited (the "Subsidiary").

As at the statement of financial position date, MLTI had subscribed for
redeemable A ordinary shares of £0.01 each in the Subsidiary entitling it to
100 percent of the incentive value.

Preferred Return

The incentive arrangements are subject to the Company's shareholders achieving
a preferred return of at least 7.5 percent per annum on a compounded basis on
the capital they have invested time to time (with dividends and returns of
capital being treated as a reduction in the amount invested at the relevant
time) (the "Preferred Return").

Incentive Value

Subject to a number of provisions detailed below, if the Preferred Return and
at least one of the vesting conditions have been met, the holders of the
Incentive Shares can give notice to redeem their Incentive Shares for ordinary
shares in the Company ("Ordinary Shares") for an aggregate value equivalent to
20 percent of the "Growth", where Growth means the excess of the total equity
value of the Company and other shareholder returns over and above its
aggregate paid up share capital (20 percent of the Growth being the "Incentive
Value").

Grant date

The grant date of the Incentive Shares is the date that such shares are
issued.

Redemption / Exercise

Unless otherwise determined and subject to the redemption conditions having
been met, the Company and the holders of the Incentive Shares have the right
to exchange each Incentive Share for Ordinary Shares in the Company, which
will be dilutive to the interests of the holders of Ordinary Shares. However,
if the Company has sufficient cash resources and the Company so determines,
the Incentive Shares may instead be redeemed for cash. It is currently
expected that in the ordinary course of business, the Incentive Shares will be
exchanged for Ordinary Shares. However, the Company retains the right but not
the obligation to redeem the Incentive Shares for cash instead. Circumstances
where the Company may exercise this right include, but are not limited to,
where the Company is not authorised to issue additional Ordinary Shares or on
the winding-up or takeover of the Company.

Any holder of Incentive Shares who exercises their Incentive Shares prior to
other holders is entitled to their proportion of the Incentive Value to the
date that they exercise but no more. Their proportion is determined by the
number of Incentive Shares they hold relative to the total number of issued
shares of the same class.

Vesting Conditions and Vesting Period

The Incentive Shares are subject to certain vesting conditions, at least one
of which must be (and continue to be) satisfied in order for a holder of
Incentive Shares to exercise its redemption right.

The vesting conditions are as follows:

i.              it is later than the third anniversary of the
initial acquisition and earlier than the seventh anniversary of the
Acquisition;

ii.             a sale of all or substantially all of the revenue
or net assets of the business of the Subsidiary in combination with the
distribution of the net proceeds of that sale to the Company and then to its
shareholders;

iii.            a sale of all of the issued ordinary shares of the
Subsidiary or a merger of the Subsidiary in combination with the distribution
of the net proceeds of that sale or merger to the Company's shareholders;

iv.            where by corporate action or otherwise, the Company
effects an in-specie distribution of all or substantially all of the assets of
the Group to the Company's shareholders;

v.             aggregate cash dividends and cash capital returns
to the Company's Shareholders are greater than or equal to aggregate
subscription proceeds received by the Company;

vi.            a winding-up of the Company;

vii.           a winding-up of the Subsidiary; or

viii.          a sale, merger or change of control of the Company.

If any of the vesting conditions described in paragraphs (ii) to (viii) above
are satisfied before the third anniversary of the initial acquisition, the A
Shares will be treated as having vested in full.

Holding of Incentive Shares

MLTI holds Incentive Shares entitling it in aggregate to 100 per cent. of the
Incentive Value. Any future management partners or senior executive management
team members receiving Incentive Shares will be dilutive to the interests of
existing holders of Incentive Shares, however the share of the Growth of the
Incentive Shares in aggregate will not increase.

The following shares were issued on 25 November 2021.

                                Nominal Price  Issue price per A ordinary share  Number of A ordinary shares  Unrestricted market value at grant date  IFRS 2 Fair value

                                                                                                              £'s

                                                   £'s                                                                                                 £'s
 Marwyn Long Term Incentive LP  £0.01          7.50                              2,000                        15,000                                   67,516

Valuation of Incentive Shares

A valuation of the incentive shares has been prepared by Deloitte LLP dated 25
November 2021 to determine the fair value of the Incentive Shares in
accordance with IFRS 2 at grant date.

There are significant estimates and assumptions used in the valuation of the
Incentive Shares. Management has considered at the grant date, the probability
of a successful first acquisition by the Company and the potential range of
value for the Incentive Shares, based on the circumstances on the grant date.

The fair value of the Incentive Shares granted under the scheme was calculated
using a Monte Carlo model. The fair value uses an ungeared volatility of 25
per cent, and an expected term of seven years. The Incentive Shares are
subject to the Preferred Return being achieved, which is a market performance
condition, and as such has been taken into consideration in determining their
fair value. A risk-free rate of 0.7 per cent. has been applied. The model
incorporates a range of probabilities for the likelihood of an acquisition
being made of a given size. As the shares issued to MLTI were deemed to vest
on issue, the full expense of £52,516 relating to the issue was recognised in
the Statement of Comprehensive Income for the period ended 30 June 2022.

 

16.  RELATED PARTY TRANSACTION

James Corsellis, Antoinette Vanderpuije and Tom Basset have served as
directors of the company during the year. James Corsellis is the managing
partner of MIM LLP, and Antoinette Vanderpuije and Tom Basset are partners of
MIM LLP, MIM LLP is the manager of the Marwyn Fund, the Marwyn Fund holds 90%
of the Company's issued ordinary share capital, 100 % of the A ordinary shares
and 1 Sponsor Share. Mark Brangstrup Watts was a director of the Company until
6 November 2022, up until this date Mark Brangstrup Watts was also a managing
partner of MIM LLP.

Marwyn Value Investors II LP is an entity within the Marwyn Fund, the Company
has entered into an FPA with Marwyn Value Investors II LP under which the
Company drew down £600,000 on 5 March 2023.

James Corsellis is the managing partner of Marwyn Capital LLP, and Antoinette
Vanderpuije and Tom Basset are also partners. Mark Brangstrup Watts was a
managing partner of Marwyn Capital LLP until 6 November 2022. Marwyn Capital
LLP provides corporate finance and managed services support including named
company secretary, to the Company. On an ongoing basis a monthly fee of
£10,000 per calendar month is charged for the provision of the corporate
finance services, and managed services support is charged by Marwyn Capital
LLP on a time spent basis. The total amount charged in the year ended 30 June
2023 by Marwyn Capital LLP was £179,612 (2022: £226,755, which included a
one-off engagement fee of £150,000 in relation to the Company's equity raise
on IPO) and they had incurred expenses on behalf of the Group, which were
subsequently recharged, of £24,109 (2022: £23,693). An amount payable to
Marwyn Capital LLP of £11,510 (2022: £29,891 was outstanding as at the year
end.

 

17.  COMMITMENTS AND CONTINGENT LIABILITIES

There were no commitments or contingent liabilities outstanding at 30 June
2023 (2022: £nil) which would require disclosure or adjustment in these
Financial Statements.

 

18.  INDEPENDENT AUDITOR'S REMUNERATION

BTCI acts as the Group's independent auditor. Audit fees payable to BTCI for
the year ended 30 June 2023 are £18,094 (2022: £15,351) (refer note 6). Fees
payable for the year ended 30 June 2023 in respect of procedures of a
potential capital markets transaction were £Nil (2022: £6,000).

 

19.  POST BALANCE SHEET EVENTS

There have been no material post balance sheet events that would require
disclosure or adjustment to these Financial Statements.

 

ADVISERS

 

 Company Secretary                                 BVI legal advisers to the Company
 Antoinette Vanderpuije                            Conyers Dill & Pearman
 11 Buckingham Street                              Commerce House
 London                                            Wickhams Cay 1
 WC2N 6DF                                          Road Town
 Email: MACAlpha@marwyn.com                        VG1110
                                                   Tortola
                                                   British Virgin Islands

 Registered Agent and Assistant Company Secretary  Depository
 Conyers Corporate Services (BVI) Limited          Link Market Services Trustees Limited
 Commerce House                                    The Registry
 Wickhams Cay 1                                    34 Beckenham Road
 Road Town                                         Beckenham
 VG1110                                            Kent
 Tortola                                           BR3 4TU
 British Virgin Islands

 English legal advisers to the Company             Registrar
 Travers Smith LLP                                 Link Market Services (Guernsey) Limited
 10 Snow Hill                                      Mont Crevelt House
 London                                            Bulwer Avenue
 EC1A 2AL                                          St Sampson
                                                   Guernsey
                                                   GY2 4LH

 Registered office                                 Independent auditor
 Commerce House                                    Baker Tilly Channel Islands Limited
 Wickhams Cay                                      1(st) Floor Kensington Chambers
 1 Road Town                                       46/50 Kensington Place
 VG1110                                            St Helier
 Tortola                                           Jersey
 British Virgin Islands                            JE04 0ZE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSMLBITMTTMBLJ

Recent news on MAC Alpha

See all news